CCM Investment Advisers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,925
| Closed | -$750K | – | 79 |
|
|
2024
Q2 | $750K | Sell |
10,925
-1,205
| -10% | -$80.4K | 0.09% | 61 |
|
|
2024
Q1 | $889K | Sell |
12,130
-130,405
| -91% | -$10M | 0.11% | 61 |
|
|
2023
Q4 | $11.5M | Sell |
142,535
-12,317
| -8% | -$958K | 1.42% | 39 |
|
|
2023
Q3 | $11.6M | Buy |
154,852
+6,258
| +4% | +$481K | 1.6% | 30 |
|
|
2023
Q2 | $11.5M | Buy |
148,594
+5,633
| +4% | +$449K | 1.54% | 32 |
|
|
2023
Q1 | $11.9M | Buy |
142,961
+36,326
| +34% | +$3.01M | 1.68% | 27 |
|
|
2022
Q4 | $9.15M | Sell |
106,635
-11,304
| -10% | -$895K | 1.45% | 39 |
|
|
2022
Q3 | $7.28M | Buy |
117,939
+13,610
| +13% | +$858K | 1.24% | 50 |
|
|
2022
Q2 | $6.45M | Sell |
104,329
-5,250
| -5% | -$325K | 1.04% | 53 |
|
|
2022
Q1 | $6.51M | Sell |
109,579
-46,149
| -30% | -$2.95M | 0.89% | 54 |
|
|
2021
Q4 | $11.3M | Buy |
155,728
+1,434
| +0.9% | +$98.8K | 1.37% | 46 |
|
|
2021
Q3 | $10.8M | Buy |
154,294
+5,372
| +4% | +$377K | 1.4% | 47 |
|
|
2021
Q2 | $10.3M | Buy |
148,922
+6,575
| +5% | +$439K | 1.31% | 51 |
|
|
2021
Q1 | $9.2M | Buy |
142,347
+9,400
| +7% | +$606K | 1.24% | 49 |
|
|
2020
Q4 | $7.75M | Sell |
132,947
-2,768
| -2% | -$167K | 1.12% | 52 |
|
|
2020
Q3 | $8.57M | Sell |
135,715
-2,711
| -2% | -$188K | 1.39% | 43 |
|
|
2020
Q2 | $10.7M | Buy |
138,426
+3,604
| +3% | +$276K | 1.82% | 24 |
|
|
2020
Q1 | $10.1M | Sell |
134,822
-1,676
| -1% | -$116K | 2.01% | 21 |
|
|
2019
Q4 | $8.87M | Buy |
136,498
+3,156
| +2% | +$206K | 1.38% | 46 |
|
|
2019
Q3 | $8.45M | Buy |
+133,342
| New | +$8.72M | 1.39% | 49 |
|
|
2017
Q1 | – | Sell |
-3,555
| Closed | -$254K | – | 96 |
|
|
2016
Q4 | $254K | Sell |
3,555
-2,900
| -45% | -$216K | 0.05% | 86 |
|
|
2016
Q3 | $510K | Sell |
6,455
-24,602
| -79% | -$2M | 0.11% | 71 |
|
|
2016
Q2 | $2.59M | Sell |
31,057
-86,592
| -74% | -$7.68M | 0.24% | 70 |
|
|
2016
Q1 | $10.8M | Sell |
117,649
-88,725
| -43% | -$8M | 1.01% | 53 |
|
|
2015
Q4 | $20.9M | Buy |
206,374
+16,366
| +9% | +$1.7M | 1.96% | 31 |
|
|
2015
Q3 | $18.7M | Buy |
190,008
+8,194
| +5% | +$910K | 1.86% | 26 |
|
|
2015
Q2 | $21.3M | Buy |
181,814
+3,949
| +2% | +$432K | 1.96% | 17 |
|
|
2015
Q1 | $17.5M | Sell |
177,865
-13,200
| -7% | -$1.34M | 1.7% | 31 |
|
|
2014
Q4 | $18M | Buy |
191,065
+5,423
| +3% | +$561K | 1.64% | 32 |
|
|
2014
Q3 | $19.8M | Sell |
185,642
-5,966
| -3% | -$584K | 1.77% | 33 |
|
|
2014
Q2 | $15.9M | Buy |
191,608
+186,103
| +3,381% | +$14.5M | 1.46% | 38 |
|
|
2014
Q1 | $390K | Buy |
5,505
+145
| +3% | +$11.4K | 0.04% | 97 |
|
|
2013
Q4 | $402K | Sell |
5,360
-30
| -0.6% | -$2.09K | 0.04% | 98 |
|
|
2013
Q3 | $338K | Sell |
5,390
-395
| -7% | -$23.6K | 0.03% | 122 |
|
|
2013
Q2 | $296K | Buy |
+5,785
| New | +$302K | 0.03% | 125 |
|
Other funds holding GILD
CCM Investment Advisers's GILD Position: Q3 2024 in Review
CCM Investment Advisers sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 10,925 shares — an estimated $750K sold.
CCM Investment Advisers first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $21.3M in Q2 2015. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.
- CCM Investment Advisers reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
- CCM Investment Advisers sold 10,925 Gilead Sciences shares in Q3 2024, an estimated $750K.
- CCM Investment Advisers first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- CCM Investment Advisers's Gilead Sciences position peaked at $21.3M in Q2 2015.
- 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.
Based on CCM Investment Advisers's 13F filing for Q3 2024, filed 9 Oct 2024.